Creatus Biosciences Inc. acquires the exclusive option to IP Assets from Stora Enso to Commercialize Xylitol Bioproduction from Biomass

with No Comments

Vancouver, BC – October 20th, 2021 / Creatus Biosciences Inc. (“Creatus”) have signed a purchase agreement with Virdia, LLC (“Virdia”), a wholly-owned subsidiary of Stora Enso Oyj (“Stora Enso”) to commercialize end-to-end production of xylitol by fermentation from biomass. The agreement sees Creatus acquire the exclusive option to all IP assets of Virdia’s technology platform, which converts lignocellulosic biomass to high quality fermentable sugars and lignin.

Download Release

Creatus Announces Patent Issuance, Close of Financing and Pilot Demonstration in 2019 Year Review

with No Comments

Vancouver, Canada, January 27, 2020 – Creatus Biosciences Inc. (Creatus), announced today in its 2019 year review that it has received issuance of a core patent related to its Xylitol Bioproduction System by the US Patent Office. The company also announced that it closed a US $1.5m financing and achieved pilot scale demonstration of its Xylitol Bioproduction System at an independent contract research organization…

Download Release